Table 2 Objective responses
2a. ITT on all enrolled patients | ||||||
|---|---|---|---|---|---|---|
| Â | Arm A (EV) (54) | Â | Arm B (PLD/V) (50) | Â | ||
| Â | No. | % | Â | No. | % | Â |
CR | 3 | 5.6 | 42.6% | 8 | 16.0 | 52.0% |
PR | 20 | 37.0 | 42.6% | 18 | 36.0 | 52.0% |
NC | 19 | 35.2 | Â | 12 | 24.0 | Â |
PD | 6 | 11.1 | Â | 9 | 18.0 | Â |
2b. On evaluable patients | ||||||
| Â | Arm A (EV) (54) | Â | Arm B (PLD/V) (47) | Â | ||
| Â | No. | % | Â | No. | % | Â |
CR | 3 | 6.3 | 47.9% | 8 | 17.0 | 55.3% |
PR | 20 | 41.6 | 47.9% | 18 | 38.7 | 55.3% |
NC | 19 | 39.6 | Â | 12 | 25.5 | Â |
PD | 6 | 12.5 | Â | 9 | 19.2 | Â |
2c. Overall response rates according to disease sites in evaluable patients (%) | ||||||
| Â | Arm A (EV) (48) | Â | Arm B (PLD/V) (47) | Â | ||
Soft tissue | 66.6 | Â | 77.7 | Â | ||
Bone | 33.3 | Â | 37.5 | Â | ||
Viscera | 50. | Â | 53.3 | Â | ||